US sets new record with nearly 290,000 COVID cases in 24 hours

The United States hit a new record for coronavirus cases Friday, notching nearly 290,000 in a…

How many people need to get a COVID-19 vaccine in order to stop the coronavirus?

It has been clear for a while that, at least in the U.S., the only way…

Link found between self-control in childhood and success later in life

An international team of researchers has found a link between degree of self-control during childhood and…

Five things to know about landmark UK vaccine

Cheap and easy to store, the AstraZeneca/Oxford vaccine which is to be rolled out in Britain…

Nanoparticle drug-delivery system developed to treat brain disorders

In the past few decades, researchers have identified biological pathways leading to neurodegenerative diseases and developed…

Traditional Ghanaian medicines show promise against tropical diseases

The discovery of new drugs is vital to achieving the eradication of neglected tropical diseases (NTDs)…

When working out makes you sick to your stomach: What to know about exercise-induced nausea

You’re doing it! You’re working out, reaping all those benefits of exercise that have been drilled…

The two sides of inflammation—the cure and the curse

One of the many wonders—and mysteries—of human biology is the complex response of the innate immune…

Morocco orders 65 million vaccine doses

Morocco said Thursday it had ordered 65 million doses of novel coronavirus vaccine, as the North…

Global trial reveals life saving drug for acute myeloid leukemia

A landmark paper published today in the New England Journal of Medicine describes the results from…

Parts of Sydney locked down as Australia battles growing cluster

Parts of Sydney were heading into a fresh lockdown on Saturday as officials in Australia’s most…

Seizure risk forecasted days in advance with brain implant data

Patterns of brain activity can be used to forecast seizure risk in epilepsy patients several days…

Much of the world may not have access to a COVID-19 vaccine until 2022

Nearly a quarter of the world’s population may not have access to a COVID-19 vaccine until…

Researcher uses fruit for less toxic drug delivery

University of Louisville researchers have found a less toxic way to deliver medicines by using the…

Ireland eases Covid-19 lockdown restrictions ahead of Christmas

Ireland on Friday announced a staggered easing of coronavirus lockdown restrictions to allow some businesses to…

UK asks regulator to study AstraZeneca vaccine

The British government said on Friday it has asked its independent medicines regulator to assess AstraZeneca’s…

Coronavirus treatments: some progress, no panacea

Nearly a year after a mysterious pneumonia emerged in China and began its global spread, there…

Scientists provide insights into the quality of life of bariatric surgery patients

In today’s issue of the Annals of Surgery, epidemiologists from the University of Pittsburgh published two…

UK leader to end England’s coronavirus lockdown on Dec. 2

British Prime Minister Boris Johnson plans to end an England-wide lockdown as scheduled on Dec. 2…

Breakthrough in childhood brain cancer will save lives

A scientific breakthrough has enabled experts to predict relapse in a common childhood cancer and means…

New York fights virus resurgence as global daily deaths top 10,000

New York battled to fend off a second wave of coronavirus infections with new restrictions on…

What are we drinking during the pandemic?

It might not be surprising to learn but people are drinking more than usual during the…

No, deodorant does not cause breast cancer! Myths a radiologist must keep debunking

Let’s talk breasts. It’s a topic Dr. Amy Patel spends a lot of time discussing in…

Johnson & Johnson prepares to resume COVID vaccine trial in US

Johnson & Johnson said Friday it was preparing to resume the clinical trial of its experimental…

Ireland steeled for start of second virus lockdown

Ireland on Wednesday braced for the start of a second nationwide coronavirus lockdown, with fears the…

Millions in England under new virus restrictions

About 28 million people in England, more than half the population, are now living under tough…

Covid-19 reinfection casts doubt on virus immunity: study

COVID-19 patients may experience more severe symptoms the second time they are infected, according to research…

Britain readies three-tiered COVID curbs next week

British Prime Minister Boris Johnson is expected next week to outline a new three-tier lockdown system…

Novel radioimmunotherapy reverses resistance to commonly used lymphoma drug

A new radioimmunotherapy has proven effective in reversing resistance to the most commonly used lymphoma drug,…

Supercharged ‘clones’ spark scarlet fever’s re-emergence

A University of Queensland-led team of international researchers says supercharged “clones” of the bacteria Streptococcus pyogenes…